Literature DB >> 3877860

Mechanism of recovery from acute virus infection. II. Effect of treatment of mice with cyclosporin A on their ability to eliminate the lymphocytic choriomeningitis virus.

C Löliger, F Lehmann-Grube.   

Abstract

Illness and death of mice infected by intracerebral inoculation with lymphocytic choriomeningitis virus are pathologic immune phenomena, and mice thus infected were protected when immunosuppressed with cyclosporin A (CSA), although the virus multiplied extensively in all major organs. Concentrations remained high as long as the drug was administered but declined when the treatment was discontinued; also, cytotoxic T lymphocytes appeared. Virus elimination was slower and cytotoxic T cell activity lower than in mice not previously treated with CSA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877860     DOI: 10.1007/bf02123695

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  33 in total

1.  THE ROLE OF ANTIGEN DOSAGE IN DRUG-INDUCED IMMUNOLOGIC TOLERANCE.

Authors:  R S SCHWARTZ; W DAMESHEK
Journal:  J Immunol       Date:  1963-05       Impact factor: 5.422

2.  Folic acid deficiency and the sparing of mice infected with the virus of lymphocytic choriomeningitis.

Authors:  V H HAAS; S E STEWART; G M BRIGGS
Journal:  Virology       Date:  1957-02       Impact factor: 3.616

3.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

4.  Studies on immunological tolerance to LCM virus. 9. Induction of immunological tolerance to the virus in the adult mouse.

Authors:  J H Larsen
Journal:  Acta Pathol Microbiol Scand       Date:  1968

5.  Studies on long-term T-cell-mediated immunity to Epstein-BArr virus in immunosuppressed renal allograft recipients.

Authors:  D H Crawford; J M Edwards; P Sweny; A V Hoffbrand; G Janossy
Journal:  Int J Cancer       Date:  1981-12       Impact factor: 7.396

6.  Beneficial effect of cyclosporin A on the lymphocytic choriomeningitis virus infection in mice.

Authors:  M F Saron; B Shidani; J C Guillon; P Truffa-Bachi
Journal:  Eur J Immunol       Date:  1984-11       Impact factor: 5.532

7.  Kinetics of unresponsiveness induced by a short course of cyclosporin A.

Authors:  T Nagao; D J White; R Y Calne
Journal:  Transplantation       Date:  1982-01       Impact factor: 4.939

8.  The effect of immunosuppressive therapy of the murine lymphocytic choriomeningitis virus infection.

Authors:  J H Larsen
Journal:  Acta Pathol Microbiol Scand       Date:  1969

9.  In vivo effects of cyclosporine on influenza A virus-infected mice.

Authors:  E Schiltknecht; G L Ada
Journal:  Cell Immunol       Date:  1985-03       Impact factor: 4.868

10.  Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice.

Authors:  F Lehmann-Grube; U Assmann; C Löliger; D Moskophidis; J Löhler
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

View more
  3 in total

1.  Cyclosporin A modulation of the acute inflammatory response: an explanation for the effect of CsA on host defences in infection.

Authors:  D J Ormrod; S Cawley; T E Miller
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

2.  Cellular basis of host defence in pyelonephritis. III. Deletion of individual components.

Authors:  T E Miller; G Findon; S Cawley
Journal:  Br J Exp Pathol       Date:  1987-06

3.  Effect of cyclosporin A on an experimental chronic viral infection of the central nervous system.

Authors:  O Boespflug; C Godfraind; M Tardieu
Journal:  J Neuroimmunol       Date:  1989-01       Impact factor: 3.478

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.